PA
LLY icon

Procyon Advisors’s Eli Lilly LLY Stock Holding History

Procyon Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.69M Sell
6,408
-691
-10% -$706K 0.33% 69
2026
Q1 		$6.53M Sell
7,099
-128
-2% -$130K 0.32% 70
2025
Q4 		$7.77M Buy
7,227
+4,616
+177% +$4.41M 0.38% 59
2025
Q3 		$1.99M Buy
2,611
+35
+1% +$26K 0.12% 143
2025
Q2 		$2.01M Sell
2,576
-1,659
-39% -$1.29M 0.19% 104
2025
Q1 		$3.5M Buy
4,235
+293
+7% +$244K 0.21% 104
2024
Q4 		$3.04M Buy
3,942
+419
+12% +$347K 0.19% 113
2024
Q3 		$3.12M Sell
3,523
-82
-2% -$73.7K 0.21% 102
2024
Q2 		$3.26M Buy
3,605
+12
+0.3% +$9.6K 0.24% 95
2024
Q1 		$2.8M Sell
3,593
-231
-6% -$164K 0.22% 110
2023
Q4 		$2.23M Buy
3,824
+514
+16% +$300K 0.19% 126
2023
Q3 		$1.78M Buy
3,310
+888
+37% +$458K 0.18% 129
2023
Q2 		$1.14M Buy
2,422
+100
+4% +$41.9K 0.14% 152
2023
Q1 		$797K Buy
2,322
+228
+11% +$76.9K 0.13% 155
2022
Q4 		$766K Buy
2,094
+760
+57% +$269K 0.14% 150
2022
Q3 		$431K Sell
1,334
-308
-19% -$97.6K 0.11% 186
2022
Q2 		$532K Buy
1,642
+20
+1% +$6K 0.12% 170
2022
Q1 		$464K Sell
1,622
-308
-16% -$79.3K 0.1% 199
2021
Q4 		$533K Sell
1,930
-96
-5% -$24.3K 0.11% 169
2021
Q3 		$468K Buy
2,026
+20
+1% +$4.94K 0.12% 167
2021
Q2 		$460K Buy
2,006
+75
+4% +$15.1K 0.13% 153
2021
Q1 		$361K Sell
1,931
-1
-0.1% -$196 0.16% 149
2020
Q4 		$326K Sell
1,932
-275
-12% -$41.1K 0.16% 151
2020
Q3 		$327K Buy
2,207
+62
+3% +$9.6K 0.18% 128
2020
Q2 		$352K Sell
2,145
-218
-9% -$33.5K 0.19% 112
2020
Q1 		$328K Buy
2,363
+118
+5% +$16.2K 0.22% 97
2019
Q4 		$295K Buy
+2,245
New +$260K 0.18% 115

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Procyon Advisors's LLY Position: Q2 2026 in Review

Procyon Advisors reduced its Eli Lilly (LLY) stake by 9.7% in Q2 2026, selling an estimated $706K and leaving 6,408 shares worth $7.69M. The position accounts for 0.33% of the portfolio, ranked #69.

Procyon Advisors first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.77M in Q4 2025. 1,632 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Procyon Advisors held 6,408 shares of Eli Lilly worth $7.69M as of Q2 2026.
  • Procyon Advisors sold 691 Eli Lilly shares in Q2 2026, an estimated $706K.
  • Eli Lilly made up 0.33% of Procyon Advisors's portfolio in Q2 2026, its #69 holding.
  • Procyon Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Procyon Advisors's Eli Lilly position peaked at $7.77M in Q4 2025.
  • 1,632 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.